MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-14-2026
Biomerica Total Current Liabilities 2011-2026 | BMRA
Annual Total Current Liabilities Biomerica
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.74 M | 2.2 M | 1.94 M | 2.01 M | 1.3 M | 1.48 M | 1.26 M | 897 K | 529 K | 506 K | 524 K | 556 K | 560 K | 592 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.2 M | 506 K | 1.15 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
1.97 M | $ 3.05 | -1.62 % | $ 99 K |  USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 34.5 | 2.16 % | $ 371 M |  China |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.24 | -15.65 % | $ 1.58 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 39.73 | 1.44 % | $ 1.1 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
5.75 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
6.8 B | $ 219.15 | -0.14 % | $ 160 B | USA |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 102.44 | 0.13 % | $ 19 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 26.14 | -0.38 % | $ 790 M | USA |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Guardant Health
GH
|
226 M | $ 113.64 | 2.86 % | $ 13.9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
1.56 B | $ 73.4 | -0.81 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 20.69 | -0.53 % | $ 1.11 B | USA |
 |
Celcuity
CELC
|
31.7 M | $ 109.42 | -2.41 % | $ 4.32 B | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 9.94 | -3.54 % | $ 282 M | Israel |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 66.97 | 0.44 % | $ 4.63 B | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 145.56 | -2.76 % | $ 23.1 B | USA |
 |
NeoGenomics
NEO
|
301 M | $ 12.04 | -2.9 % | $ 1.52 B | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 231.17 | -1.83 % | $ 41.9 B | USA |
 |
Charles River Laboratories International
CRL
|
994 M | $ 210.54 | -0.57 % | $ 10.8 B | USA |
 |
Medpace Holdings
MEDP
|
1.1 B | $ 585.64 | -1.25 % | $ 18.1 B | USA |
 |
Personalis
PSNL
|
31.1 M | $ 9.43 | -5.42 % | $ 559 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 186.85 | 2.49 % | $ 20.7 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 9.94 | 2.85 % | $ 1.29 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
3.14 M | $ 24.53 | 1.11 % | $ 31.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 271.48 | 0.62 % | $ 22.8 B | USA |
 |
Mettler-Toledo International
MTD
|
1.17 B | $ 1 381.85 | -0.79 % | $ 29.3 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 180.78 | -2.75 % | $ 14.9 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.07 B | $ 674.26 | -0.36 % | $ 55.6 B | USA |
 |
Agilent Technologies
A
|
1.71 B | $ 133.38 | 0.11 % | $ 40.5 B | USA |